nodes	percent_of_prediction	percent_of_DWPC	metapath
Telbivudine—Disease progression—Carmustine—melanoma	0.0436	0.0448	CcSEcCtD
Telbivudine—Non-cardiac chest pain—Docetaxel—melanoma	0.0353	0.0363	CcSEcCtD
Telbivudine—Multi-organ failure—Dactinomycin—melanoma	0.0312	0.0321	CcSEcCtD
Telbivudine—Zidovudine—TERT—melanoma	0.0221	0.817	CrCbGaD
Telbivudine—Multi-organ failure—Docetaxel—melanoma	0.0188	0.0193	CcSEcCtD
Telbivudine—Musculoskeletal pain—Vemurafenib—melanoma	0.0182	0.0187	CcSEcCtD
Telbivudine—Hepatomegaly—Dactinomycin—melanoma	0.0144	0.0148	CcSEcCtD
Telbivudine—Myopathy—Temozolomide—melanoma	0.0131	0.0135	CcSEcCtD
Telbivudine—Pain in extremity—Vemurafenib—melanoma	0.0131	0.0134	CcSEcCtD
Telbivudine—Influenza-like symptoms—Temozolomide—melanoma	0.0129	0.0132	CcSEcCtD
Telbivudine—Tenderness—Bleomycin—melanoma	0.0125	0.0129	CcSEcCtD
Telbivudine—Neuropathy peripheral—Vemurafenib—melanoma	0.00987	0.0101	CcSEcCtD
Telbivudine—Neck pain—Carmustine—melanoma	0.00964	0.00991	CcSEcCtD
Telbivudine—Musculoskeletal pain—Temozolomide—melanoma	0.00931	0.00957	CcSEcCtD
Telbivudine—Pharyngolaryngeal pain—Docetaxel—melanoma	0.00907	0.00932	CcSEcCtD
Telbivudine—Laryngeal pain—Docetaxel—melanoma	0.00898	0.00923	CcSEcCtD
Telbivudine—Influenza like illness—Temozolomide—melanoma	0.00894	0.00919	CcSEcCtD
Telbivudine—Connective tissue disorder—Vemurafenib—melanoma	0.00889	0.00913	CcSEcCtD
Telbivudine—Sepsis—Dactinomycin—melanoma	0.00883	0.00908	CcSEcCtD
Telbivudine—Sepsis—Carmustine—melanoma	0.00826	0.00849	CcSEcCtD
Telbivudine—Mediastinal disorder—Vemurafenib—melanoma	0.00815	0.00838	CcSEcCtD
Telbivudine—Malnutrition—Vemurafenib—melanoma	0.00787	0.00809	CcSEcCtD
Telbivudine—Dysgeusia—Vemurafenib—melanoma	0.00771	0.00792	CcSEcCtD
Telbivudine—Back pain—Vemurafenib—melanoma	0.00761	0.00783	CcSEcCtD
Telbivudine—Rhinorrhoea—Docetaxel—melanoma	0.00755	0.00776	CcSEcCtD
Telbivudine—Chest discomfort—Docetaxel—melanoma	0.00692	0.00711	CcSEcCtD
Telbivudine—Cough—Vemurafenib—melanoma	0.00687	0.00706	CcSEcCtD
Telbivudine—Myalgia—Vemurafenib—melanoma	0.0067	0.00689	CcSEcCtD
Telbivudine—Arthralgia—Vemurafenib—melanoma	0.0067	0.00689	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00666	0.00684	CcSEcCtD
Telbivudine—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.00665	0.00684	CcSEcCtD
Telbivudine—Nervous system disorder—Vemurafenib—melanoma	0.0063	0.00648	CcSEcCtD
Telbivudine—Skin disorder—Vemurafenib—melanoma	0.00624	0.00641	CcSEcCtD
Telbivudine—Muscular weakness—Carmustine—melanoma	0.0061	0.00627	CcSEcCtD
Telbivudine—Aspartate aminotransferase increased—Temozolomide—melanoma	0.00602	0.00618	CcSEcCtD
Telbivudine—Neutropenia—Dactinomycin—melanoma	0.00597	0.00614	CcSEcCtD
Telbivudine—Influenza like illness—Docetaxel—melanoma	0.00594	0.00611	CcSEcCtD
Telbivudine—Alanine aminotransferase increased—Temozolomide—melanoma	0.00589	0.00606	CcSEcCtD
Telbivudine—Muscular weakness—Temozolomide—melanoma	0.00589	0.00606	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00585	0.00602	CcSEcCtD
Telbivudine—Abdominal distension—Temozolomide—melanoma	0.00581	0.00597	CcSEcCtD
Telbivudine—Neutropenia—Carmustine—melanoma	0.00559	0.00574	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Vemurafenib—melanoma	0.00555	0.0057	CcSEcCtD
Telbivudine—Fatigue—Vemurafenib—melanoma	0.00554	0.00569	CcSEcCtD
Telbivudine—Hypoaesthesia—Bleomycin—melanoma	0.00545	0.0056	CcSEcCtD
Telbivudine—Neutropenia—Temozolomide—melanoma	0.0054	0.00555	CcSEcCtD
Telbivudine—Upper respiratory tract infection—Temozolomide—melanoma	0.00537	0.00552	CcSEcCtD
Telbivudine—Sepsis—Docetaxel—melanoma	0.00531	0.00546	CcSEcCtD
Telbivudine—Renal failure—Carmustine—melanoma	0.00524	0.00538	CcSEcCtD
Telbivudine—Neuropathy peripheral—Carmustine—melanoma	0.00522	0.00537	CcSEcCtD
Telbivudine—Hepatitis—Dactinomycin—melanoma	0.00511	0.00525	CcSEcCtD
Telbivudine—Body temperature increased—Vemurafenib—melanoma	0.00508	0.00522	CcSEcCtD
Telbivudine—Pharyngitis—Dactinomycin—melanoma	0.00507	0.00521	CcSEcCtD
Telbivudine—Neuropathy peripheral—Temozolomide—melanoma	0.00505	0.00519	CcSEcCtD
Telbivudine—Hepatobiliary disease—Temozolomide—melanoma	0.00487	0.005	CcSEcCtD
Telbivudine—Hypoaesthesia—Carmustine—melanoma	0.00476	0.00489	CcSEcCtD
Telbivudine—Connective tissue disorder—Carmustine—melanoma	0.0047	0.00483	CcSEcCtD
Telbivudine—Renal impairment—Docetaxel—melanoma	0.00467	0.0048	CcSEcCtD
Telbivudine—Hepatitis—Temozolomide—melanoma	0.00462	0.00475	CcSEcCtD
Telbivudine—Asthenia—Vemurafenib—melanoma	0.00461	0.00474	CcSEcCtD
Telbivudine—Hypoaesthesia—Temozolomide—melanoma	0.0046	0.00473	CcSEcCtD
Telbivudine—Pharyngitis—Temozolomide—melanoma	0.00459	0.00471	CcSEcCtD
Telbivudine—Pruritus—Vemurafenib—melanoma	0.00455	0.00467	CcSEcCtD
Telbivudine—Connective tissue disorder—Temozolomide—melanoma	0.00454	0.00467	CcSEcCtD
Telbivudine—Pain in extremity—Docetaxel—melanoma	0.00444	0.00457	CcSEcCtD
Telbivudine—Ill-defined disorder—Bleomycin—melanoma	0.00443	0.00455	CcSEcCtD
Telbivudine—Diarrhoea—Vemurafenib—melanoma	0.0044	0.00452	CcSEcCtD
Telbivudine—Migraine—Docetaxel—melanoma	0.00437	0.00449	CcSEcCtD
Telbivudine—Malaise—Bleomycin—melanoma	0.0043	0.00442	CcSEcCtD
Telbivudine—Dizziness—Vemurafenib—melanoma	0.00425	0.00437	CcSEcCtD
Telbivudine—Mediastinal disorder—Temozolomide—melanoma	0.00417	0.00428	CcSEcCtD
Telbivudine—Malnutrition—Carmustine—melanoma	0.00416	0.00428	CcSEcCtD
Telbivudine—Cough—Bleomycin—melanoma	0.00416	0.00428	CcSEcCtD
Telbivudine—Ill-defined disorder—Dactinomycin—melanoma	0.00413	0.00424	CcSEcCtD
Telbivudine—Vomiting—Vemurafenib—melanoma	0.00408	0.0042	CcSEcCtD
Telbivudine—Chest pain—Bleomycin—melanoma	0.00406	0.00417	CcSEcCtD
Telbivudine—Myalgia—Bleomycin—melanoma	0.00406	0.00417	CcSEcCtD
Telbivudine—Abdominal pain upper—Docetaxel—melanoma	0.00406	0.00417	CcSEcCtD
Telbivudine—Rash—Vemurafenib—melanoma	0.00405	0.00416	CcSEcCtD
Telbivudine—Dermatitis—Vemurafenib—melanoma	0.00405	0.00416	CcSEcCtD
Telbivudine—Back pain—Carmustine—melanoma	0.00403	0.00414	CcSEcCtD
Telbivudine—Headache—Vemurafenib—melanoma	0.00402	0.00414	CcSEcCtD
Telbivudine—Malnutrition—Temozolomide—melanoma	0.00402	0.00413	CcSEcCtD
Telbivudine—Discomfort—Bleomycin—melanoma	0.00401	0.00412	CcSEcCtD
Telbivudine—Malaise—Dactinomycin—melanoma	0.00401	0.00412	CcSEcCtD
Telbivudine—Cramp muscle—Docetaxel—melanoma	0.004	0.00411	CcSEcCtD
Telbivudine—Aspartate aminotransferase increased—Docetaxel—melanoma	0.004	0.00411	CcSEcCtD
Telbivudine—Nasopharyngitis—Docetaxel—melanoma	0.00397	0.00408	CcSEcCtD
Telbivudine—Dysgeusia—Temozolomide—melanoma	0.00394	0.00405	CcSEcCtD
Telbivudine—Alanine aminotransferase increased—Docetaxel—melanoma	0.00392	0.00403	CcSEcCtD
Telbivudine—Back pain—Temozolomide—melanoma	0.00389	0.004	CcSEcCtD
Telbivudine—Nausea—Vemurafenib—melanoma	0.00382	0.00392	CcSEcCtD
Telbivudine—Thrombocytopenia—Bleomycin—melanoma	0.00381	0.00392	CcSEcCtD
Telbivudine—Myalgia—Dactinomycin—melanoma	0.00379	0.00389	CcSEcCtD
Telbivudine—Discomfort—Dactinomycin—melanoma	0.00374	0.00385	CcSEcCtD
Telbivudine—Ill-defined disorder—Temozolomide—melanoma	0.00373	0.00384	CcSEcCtD
Telbivudine—Malaise—Temozolomide—melanoma	0.00363	0.00373	CcSEcCtD
Telbivudine—Neutropenia—Docetaxel—melanoma	0.00359	0.00369	CcSEcCtD
Telbivudine—Thrombocytopenia—Dactinomycin—melanoma	0.00355	0.00365	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Bleomycin—melanoma	0.00355	0.00364	CcSEcCtD
Telbivudine—Myalgia—Carmustine—melanoma	0.00354	0.00364	CcSEcCtD
Telbivudine—Chest pain—Carmustine—melanoma	0.00354	0.00364	CcSEcCtD
Telbivudine—Cough—Temozolomide—melanoma	0.00351	0.00361	CcSEcCtD
Telbivudine—Paraesthesia—Bleomycin—melanoma	0.0035	0.00359	CcSEcCtD
Telbivudine—Arthralgia—Temozolomide—melanoma	0.00343	0.00352	CcSEcCtD
Telbivudine—Myalgia—Temozolomide—melanoma	0.00343	0.00352	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.0034	0.0035	CcSEcCtD
Telbivudine—Discomfort—Temozolomide—melanoma	0.00338	0.00348	CcSEcCtD
Telbivudine—Renal failure—Docetaxel—melanoma	0.00337	0.00346	CcSEcCtD
Telbivudine—Neuropathy peripheral—Docetaxel—melanoma	0.00336	0.00345	CcSEcCtD
Telbivudine—Pain—Bleomycin—melanoma	0.00333	0.00342	CcSEcCtD
Telbivudine—Thrombocytopenia—Carmustine—melanoma	0.00333	0.00342	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00331	0.0034	CcSEcCtD
Telbivudine—Hepatobiliary disease—Docetaxel—melanoma	0.00324	0.00333	CcSEcCtD
Telbivudine—Nervous system disorder—Temozolomide—melanoma	0.00322	0.00331	CcSEcCtD
Telbivudine—Thrombocytopenia—Temozolomide—melanoma	0.00321	0.0033	CcSEcCtD
Telbivudine—Feeling abnormal—Bleomycin—melanoma	0.00321	0.0033	CcSEcCtD
Telbivudine—Skin disorder—Temozolomide—melanoma	0.00319	0.00328	CcSEcCtD
Telbivudine—Fatigue—Dactinomycin—melanoma	0.00313	0.00322	CcSEcCtD
Telbivudine—Pain—Dactinomycin—melanoma	0.0031	0.00319	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Carmustine—melanoma	0.0031	0.00318	CcSEcCtD
Telbivudine—Body temperature increased—Bleomycin—melanoma	0.00308	0.00316	CcSEcCtD
Telbivudine—Hepatitis—Docetaxel—melanoma	0.00307	0.00316	CcSEcCtD
Telbivudine—Insomnia—Carmustine—melanoma	0.00307	0.00316	CcSEcCtD
Telbivudine—Hypoaesthesia—Docetaxel—melanoma	0.00306	0.00314	CcSEcCtD
Telbivudine—Paraesthesia—Carmustine—melanoma	0.00305	0.00314	CcSEcCtD
Telbivudine—Pharyngitis—Docetaxel—melanoma	0.00305	0.00314	CcSEcCtD
Telbivudine—Connective tissue disorder—Docetaxel—melanoma	0.00302	0.0031	CcSEcCtD
Telbivudine—Feeling abnormal—Dactinomycin—melanoma	0.00299	0.00307	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Temozolomide—melanoma	0.00299	0.00307	CcSEcCtD
Telbivudine—Insomnia—Temozolomide—melanoma	0.00297	0.00305	CcSEcCtD
Telbivudine—Gastrointestinal pain—Dactinomycin—melanoma	0.00297	0.00305	CcSEcCtD
Telbivudine—Paraesthesia—Temozolomide—melanoma	0.00295	0.00303	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Carmustine—melanoma	0.00293	0.00301	CcSEcCtD
Telbivudine—Pain—Carmustine—melanoma	0.00291	0.00299	CcSEcCtD
Telbivudine—Dyspepsia—Temozolomide—melanoma	0.00289	0.00297	CcSEcCtD
Telbivudine—Abdominal pain—Dactinomycin—melanoma	0.00287	0.00295	CcSEcCtD
Telbivudine—Body temperature increased—Dactinomycin—melanoma	0.00287	0.00295	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Temozolomide—melanoma	0.00283	0.00291	CcSEcCtD
Telbivudine—Fatigue—Temozolomide—melanoma	0.00283	0.00291	CcSEcCtD
Telbivudine—Pain—Temozolomide—melanoma	0.00281	0.00289	CcSEcCtD
Telbivudine—Feeling abnormal—Carmustine—melanoma	0.0028	0.00288	CcSEcCtD
Telbivudine—Asthenia—Bleomycin—melanoma	0.00279	0.00287	CcSEcCtD
Telbivudine—Gastrointestinal pain—Carmustine—melanoma	0.00278	0.00286	CcSEcCtD
Telbivudine—Mediastinal disorder—Docetaxel—melanoma	0.00277	0.00285	CcSEcCtD
Telbivudine—Pruritus—Bleomycin—melanoma	0.00275	0.00283	CcSEcCtD
Telbivudine—Feeling abnormal—Temozolomide—melanoma	0.00271	0.00278	CcSEcCtD
Telbivudine—Abdominal pain—Carmustine—melanoma	0.00269	0.00276	CcSEcCtD
Telbivudine—Body temperature increased—Carmustine—melanoma	0.00269	0.00276	CcSEcCtD
Telbivudine—Gastrointestinal pain—Temozolomide—melanoma	0.00268	0.00276	CcSEcCtD
Telbivudine—Malnutrition—Docetaxel—melanoma	0.00268	0.00275	CcSEcCtD
Telbivudine—Dysgeusia—Docetaxel—melanoma	0.00262	0.00269	CcSEcCtD
Telbivudine—Asthenia—Dactinomycin—melanoma	0.0026	0.00268	CcSEcCtD
Telbivudine—Body temperature increased—Temozolomide—melanoma	0.0026	0.00267	CcSEcCtD
Telbivudine—Abdominal pain—Temozolomide—melanoma	0.0026	0.00267	CcSEcCtD
Telbivudine—Back pain—Docetaxel—melanoma	0.00259	0.00266	CcSEcCtD
Telbivudine—Muscle spasms—Docetaxel—melanoma	0.00257	0.00264	CcSEcCtD
Telbivudine—Zidovudine—ALB—melanoma	0.00253	0.0934	CrCbGaD
Telbivudine—Diarrhoea—Dactinomycin—melanoma	0.00248	0.00255	CcSEcCtD
Telbivudine—Vomiting—Bleomycin—melanoma	0.00247	0.00254	CcSEcCtD
Telbivudine—Rash—Bleomycin—melanoma	0.00245	0.00252	CcSEcCtD
Telbivudine—Dermatitis—Bleomycin—melanoma	0.00245	0.00252	CcSEcCtD
Telbivudine—Asthenia—Carmustine—melanoma	0.00244	0.00251	CcSEcCtD
Telbivudine—Zidovudine—ABCB1—melanoma	0.00241	0.0891	CrCbGaD
Telbivudine—Asthenia—Temozolomide—melanoma	0.00236	0.00242	CcSEcCtD
Telbivudine—Cough—Docetaxel—melanoma	0.00233	0.0024	CcSEcCtD
Telbivudine—Diarrhoea—Carmustine—melanoma	0.00232	0.00239	CcSEcCtD
Telbivudine—Pruritus—Temozolomide—melanoma	0.00232	0.00239	CcSEcCtD
Telbivudine—Nausea—Bleomycin—melanoma	0.00231	0.00238	CcSEcCtD
Telbivudine—Vomiting—Dactinomycin—melanoma	0.00231	0.00237	CcSEcCtD
Telbivudine—Rash—Dactinomycin—melanoma	0.00229	0.00235	CcSEcCtD
Telbivudine—Arthralgia—Docetaxel—melanoma	0.00228	0.00234	CcSEcCtD
Telbivudine—Chest pain—Docetaxel—melanoma	0.00228	0.00234	CcSEcCtD
Telbivudine—Myalgia—Docetaxel—melanoma	0.00228	0.00234	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00226	0.00232	CcSEcCtD
Telbivudine—Dizziness—Carmustine—melanoma	0.00225	0.00231	CcSEcCtD
Telbivudine—Diarrhoea—Temozolomide—melanoma	0.00225	0.00231	CcSEcCtD
Telbivudine—Dizziness—Temozolomide—melanoma	0.00217	0.00223	CcSEcCtD
Telbivudine—Vomiting—Carmustine—melanoma	0.00216	0.00222	CcSEcCtD
Telbivudine—Nausea—Dactinomycin—melanoma	0.00216	0.00222	CcSEcCtD
Telbivudine—Rash—Carmustine—melanoma	0.00214	0.0022	CcSEcCtD
Telbivudine—Nervous system disorder—Docetaxel—melanoma	0.00214	0.0022	CcSEcCtD
Telbivudine—Dermatitis—Carmustine—melanoma	0.00214	0.0022	CcSEcCtD
Telbivudine—Thrombocytopenia—Docetaxel—melanoma	0.00214	0.0022	CcSEcCtD
Telbivudine—Headache—Carmustine—melanoma	0.00213	0.00219	CcSEcCtD
Telbivudine—Skin disorder—Docetaxel—melanoma	0.00212	0.00218	CcSEcCtD
Telbivudine—Vomiting—Temozolomide—melanoma	0.00209	0.00215	CcSEcCtD
Telbivudine—Rash—Temozolomide—melanoma	0.00207	0.00213	CcSEcCtD
Telbivudine—Dermatitis—Temozolomide—melanoma	0.00207	0.00213	CcSEcCtD
Telbivudine—Headache—Temozolomide—melanoma	0.00206	0.00211	CcSEcCtD
Telbivudine—Nausea—Carmustine—melanoma	0.00202	0.00207	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Docetaxel—melanoma	0.00199	0.00204	CcSEcCtD
Telbivudine—Insomnia—Docetaxel—melanoma	0.00197	0.00203	CcSEcCtD
Telbivudine—Paraesthesia—Docetaxel—melanoma	0.00196	0.00202	CcSEcCtD
Telbivudine—Nausea—Temozolomide—melanoma	0.00195	0.002	CcSEcCtD
Telbivudine—Dyspepsia—Docetaxel—melanoma	0.00192	0.00198	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Docetaxel—melanoma	0.00189	0.00194	CcSEcCtD
Telbivudine—Fatigue—Docetaxel—melanoma	0.00188	0.00193	CcSEcCtD
Telbivudine—Pain—Docetaxel—melanoma	0.00187	0.00192	CcSEcCtD
Telbivudine—Feeling abnormal—Docetaxel—melanoma	0.0018	0.00185	CcSEcCtD
Telbivudine—Gastrointestinal pain—Docetaxel—melanoma	0.00179	0.00184	CcSEcCtD
Telbivudine—Abdominal pain—Docetaxel—melanoma	0.00173	0.00177	CcSEcCtD
Telbivudine—Body temperature increased—Docetaxel—melanoma	0.00173	0.00177	CcSEcCtD
Telbivudine—Asthenia—Docetaxel—melanoma	0.00157	0.00161	CcSEcCtD
Telbivudine—Pruritus—Docetaxel—melanoma	0.00154	0.00159	CcSEcCtD
Telbivudine—Diarrhoea—Docetaxel—melanoma	0.00149	0.00154	CcSEcCtD
Telbivudine—Dizziness—Docetaxel—melanoma	0.00144	0.00148	CcSEcCtD
Telbivudine—Vomiting—Docetaxel—melanoma	0.00139	0.00143	CcSEcCtD
Telbivudine—Rash—Docetaxel—melanoma	0.00138	0.00142	CcSEcCtD
Telbivudine—Dermatitis—Docetaxel—melanoma	0.00138	0.00141	CcSEcCtD
Telbivudine—Headache—Docetaxel—melanoma	0.00137	0.00141	CcSEcCtD
Telbivudine—Nausea—Docetaxel—melanoma	0.0013	0.00133	CcSEcCtD
